Impact of CD34+Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Trans

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of CD34+Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Trans
Type de publicationJournal Article
Year of Publication2020
AuteursMaffini E, Labopin M, Blaise D, Ciceri F, Gulbas Z, Deconinck E, Leblond V, Chevallier P, Socie G, Araujo MColorado, Koc Y, Lanza F, Nagler A, Mohty M
JournalBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Volume26
PaginationS287-S288
Date PublishedMAR
Type of ArticleMeeting Abstract
ISSN1083-8791